您使用提示模式 关闭

Vertex, ordinary share
US92532F1003, VRTX

添加股票到 WL
Vertex Pharmaceutical, 国家 — 美国
不存在此交易信息
数据显示法可以选择 图形 | 表格
信息来源 - PJSC“莫斯科交易所”。未经PJSC“莫斯科交易所”授权, 禁止传播一切相关证券信息。版权所有, 违法必究。
信息来源 - PJSC“莫斯科交易所”。未经PJSC“莫斯科交易所”授权, 禁止传播一切相关证券信息。版权所有, 违法必究。
ADD-IN
Cbonds 加载项
API
债券数据 API
请求认证
需要 访问
在数据库中超过2500个条目, 请细化您的搜索范围
所选期间没有数据

最新价格

探索最全面的数据库

80 万

债券

超过 400

定价来源

8 万

股票

9 千

ETF

以最有效的方式跟踪您的投资组合
债券筛选器
观察列表
Excel 附加组件

发行人

简介
Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases. The Company’s two products are INCIVEK (telaprevir), which is approved for the treatment ...
Vertex Pharmaceuticals Incorporated (Vertex) is in the business of discovering, developing, manufacturing and commercializing small molecule drugs for the treatment of serious diseases. The Company’s two products are INCIVEK (telaprevir), which is approved for the treatment of patients with genotype 1 hepatitis C virus (HCV), infection, and KALYDECO (ivacaftor), which is approved in the United States for the treatment of patients six years of age and older with cystic fibrosis (CF), who have at least one copy of the G551D mutation in the cystic fibrosis transmembrane conductance regulator (CFTR), gene. The Company has ongoing clinical programs involving drug candidates intended for the treatment of HCV infection, CF, rheumatoid arthritis, influenza and epilepsy. / upd. 08. 2012
  • 发行人
  • 发行人 / 借款人全称
    Vertex Pharmaceuticals Incorporated
  • 行业
    药品生产和生物技术

股票指数

你必须 注册 才能获得访问权